Clinical studies recruiting near Olomouc

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Fakultni nemocnice Olomouc · Eli Lilly and Company · NCT07218380 Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Ordinace pro tbc a respirační nemoci s.r.o. · Philip Morris Products S.A. · NCT07108166 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 2030001 · Sanofi · NCT06867094 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Fakultni nemocnice Olomouc · Pfizer · NCT07028853 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · University Hospital Olomouc · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Fakultni nemocnice Olomouc ( Site 0303) · Merck Sharp & Dohme LLC · NCT06136559 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 1006) · Merck Sharp & Dohme LLC · NCT06393374 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Fakultni nemocnice Olomouc · Pfizer · NCT06758401 Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pa
NA · Fakultni nemocnice Olomouc · Lipidica, a.s. · NCT06549725 Early Detection of OAB and Elimination of Negative Impact on Quality of Life
NA · Olomouc University Hospital · Institute of Health Information and Statistics of the Czech · NCT07371000 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · PreventaMed sro · Amgen · NCT07037433 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.
Phase N/A · University Hospital Olomouc · The Institute of Molecular and Translational Medicine, Czech · NCT04157361 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Fakultni nemocnice Olomouc · Pfizer · NCT07144280 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberku · Merck Sharp & Dohme LLC · NCT06077760 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · AGE Centrum · Bristol-Myers Squibb · NCT06976216 EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
Phase 1 · Olomouc University Hospital · Epics Therapeutics · NCT07163325 A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Phase 2 · NEUMED Gynekologicka Ambulance s.r.o. · Gesynta Pharma AB · NCT07260669 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Fakultni nemocnice Olomouc · Janssen Research & Development, LLC · NCT06319820 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Fakultni nemocnice Olomouc · Daiichi Sankyo · NCT06731478 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0150 · Bristol-Myers Squibb · NCT03899155 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Fakultni nemocnice Olomouc · Pfizer · NCT06629779 Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
Phase N/A · University hospital Olomouc · University Hospital Olomouc · NCT07360886 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · University Hospital Olomouc · Boehringer Ingelheim · NCT07472517 Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Phase 4 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05803941 CARE1 Pragmatic Clinical Trial
Phase 3 · Fakultní nemocnice Olomouc, University Hospital Olomouc (FNO · Gustave Roussy, Cancer Campus, Grand Paris · NCT06364631 A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Phase 2 · Fakultní nemocnice Olomouc · Karyopharm Therapeutics Inc · NCT05980806 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05939414 A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Phase 2 · Fakultni nemocnice Olomouc - Neurologicka klinika · Ipsen · NCT06937931

Look up another city

Look up another condition